In this trial, rural communities in Niger were randomly assigned to distribute azithromycin or placebo to children (1 to 59 months of age) or infants (1 to 11 months). All-cause mortality was reduced in the child-treated group.
The New England Journal of Medicine: Search Results in Pediatrics
